Compile Data Set for Download or QSAR

Found 3 hits Enz. Inhib. hit(s) with Target = 'Vascular endothelial growth factor receptor 2' and Ligand = 'BDBM365312'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human))	BDBM365312 (US10633373, Example 31 | US10669265, Example 31 | ...) Show SMILES Cc1cccc(NC(=O)Nc2ccc3sc(cc3c2)-c2cc(cnc2N)B(O)O)c1 Show InChI InChI=1S/C21H19BN4O3S/c1-12-3-2-4-15(7-12)25-21(27)26-16-5-6-18-13(8-16)9-19(30-18)17-10-14(22(28)29)11-24-20(17)23/h2-11,28-29H,1H3,(H2,23,24)(H2,25,26,27)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	42	n/a	n/a	n/a	n/a	n/a	n/a
Amgen					Assay Description Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...				J Med Chem 50: 3515-27 (2007) BindingDB Entry DOI: 10.7270/Q2DB8465
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human))	BDBM365312 (US10633373, Example 31 | US10669265, Example 31 | ...) Show SMILES Cc1cccc(NC(=O)Nc2ccc3sc(cc3c2)-c2cc(cnc2N)B(O)O)c1 Show InChI InChI=1S/C21H19BN4O3S/c1-12-3-2-4-15(7-12)25-21(27)26-16-5-6-18-13(8-16)9-19(30-18)17-10-14(22(28)29)11-24-20(17)23/h2-11,28-29H,1H3,(H2,23,24)(H2,25,26,27)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	93	n/a	n/a	n/a	n/a	n/a	n/a
ALLERGAN, INC. US Patent					Assay Description Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...				US Patent US10669265 (2020) BindingDB Entry DOI: 10.7270/Q20R9SFZ
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human))	BDBM365312 (US10633373, Example 31 | US10669265, Example 31 | ...) Show SMILES Cc1cccc(NC(=O)Nc2ccc3sc(cc3c2)-c2cc(cnc2N)B(O)O)c1 Show InChI InChI=1S/C21H19BN4O3S/c1-12-3-2-4-15(7-12)25-21(27)26-16-5-6-18-13(8-16)9-19(30-18)17-10-14(22(28)29)11-24-20(17)23/h2-11,28-29H,1H3,(H2,23,24)(H2,25,26,27)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	93	n/a	n/a	n/a	n/a	n/a	n/a
Allergan, Inc. US Patent					Assay Description VEGFR2: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:...				US Patent US10633373 (2020) BindingDB Entry DOI: 10.7270/Q2Z60S37
					More data for this Ligand-Target Pair